At the news
? BULLISHIMPACT 6/10 3 filed Jul 15, 2026 at 19:49 ET
Kevin Tang and Tang Capital Management LLC filed a Form 3 initial statement of beneficial ownership, disclosing a 6,663,383-share stake in Fulcrum Therapeutics. This represents a new, significant position by a known activist investor, suggesting potential strategic engagement at a beaten-down biotech with a $239M market cap and largely negative analyst consensus.
- Kevin Tang and Tang Capital Management LLC filed Form 3 on 2026-07-15, reporting beneficial ownership of 6,663,383 shares of FULC common stock.
- The shares are held indirectly through Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc.
- Kevin Tang is the sole manager/director/CEO of the reporting entities, giving him control and pecuniary interest in the stake.
- The filing is an initial statement, indicating a new position by Tang Capital, a known activist investment firm.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access